- Report
- March 2025
- 250 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- December 2024
- 150 Pages
Global
From €2911EUR$3,250USD£2,481GBP
€4344EUR$4,850USD£3,703GBP
- Report
- June 2025
- 74 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 72 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- December 2024
- 200 Pages
Global
From €3359EUR$3,750USD£2,863GBP
- Report
- July 2024
- 150 Pages
Global
From €3359EUR$3,750USD£2,863GBP
- Report
- October 2018
- 450 Pages
Global
From €3134EUR$3,499USD£2,672GBP
- Report
- February 2024
- 237 Pages
Global
From €4434EUR$4,950USD£3,779GBP
- Report
- November 2023
- 120 Pages
Global
From €5329EUR$5,950USD£4,543GBP
- Report
- January 2024
- 200 Pages
Global
From €3717EUR$4,150USD£3,169GBP
- Report
- July 2023
- 160 Pages
Global
From €4433EUR$4,949USD£3,779GBP
- Report
- July 2022
- 100 Pages
Global
From €2463EUR$2,750USD£2,100GBP
- Report
- October 2023
- 190 Pages
Global
From €3426EUR$3,825USD£2,920GBP
€4031EUR$4,500USD£3,436GBP
- Report
- May 2024
- 186 Pages
Global
From €3426EUR$3,825USD£2,920GBP
€4031EUR$4,500USD£3,436GBP
- Report
- April 2023
- 112 Pages
Global
From €4255EUR$4,750USD£3,627GBP
- Report
- April 2023
- 120 Pages
Global
From €4255EUR$4,750USD£3,627GBP
- Report
- April 2024
- 135 Pages
Global
From €3538EUR$3,950USD£3,016GBP
- Report
- May 2022
- 255 Pages
Global
From €3224EUR$3,600USD£2,749GBP
- Report
- May 2022
- 106 Pages
Middle East, Africa
From €1344EUR$1,500USD£1,145GBP
- Report
- May 2022
- 106 Pages
Asia Pacific
From €1344EUR$1,500USD£1,145GBP

The Wearable Injector market is a subset of the Infusions and Injectables market, which includes a variety of medical devices used to deliver drugs, fluids, and other substances directly into a patient's body. Wearable Injectors are a type of infusion device that are designed to be worn on the body, allowing for continuous or periodic drug delivery. These devices are typically used to deliver medications such as insulin, hormones, and antibiotics, and can be used to treat a variety of conditions. Wearable Injectors offer a number of advantages over traditional infusion methods, including improved patient compliance, increased accuracy of drug delivery, and improved safety.
Some of the major players in the Wearable Injector market include Insulet Corporation, Valeritas, Inc., Becton Dickinson and Company, Tandem Diabetes Care, Inc., and Ypsomed AG. Show Less Read more